BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28126499)

  • 1. Bacillus Calmette-Guerin improves local and systemic response to radiotherapy in invasive bladder cancer.
    Prack Mc Cormick B; Belgorosky D; Langle Y; Balarino N; Sandes E; Eiján AM
    Nitric Oxide; 2017 Apr; 64():22-30. PubMed ID: 28126499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nitric oxide inhibition in Bacillus Calmette-Guerin bladder cancer treatment.
    Langle YV; Balarino NP; Belgorosky D; Cresta Morgado PD; Sandes EO; Marino L; Bilbao ER; Zambrano M; Lodillinsky C; Eiján AM
    Nitric Oxide; 2020 May; 98():50-59. PubMed ID: 32147582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment.
    Alvarez V; Lodillinsky C; Umerez S; Sandes E; Eiján AM
    Int J Mol Med; 2005 Oct; 16(4):565-71. PubMed ID: 16142388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGFR3 Down-Regulation is Involved in bacillus Calmette-Guérin Induced Bladder Tumor Growth Inhibition.
    Langle YV; Belgorosky D; Prack McCormick B; Sahores A; Góngora A; Baldi A; Lanari C; Lamb C; Eiján AM
    J Urol; 2016 Jan; 195(1):188-97. PubMed ID: 26144336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD4+ T-cell immunity.
    Mangsbo SM; Ninalga C; Essand M; Loskog A; Tötterman TH
    J Immunother; 2008 Jan; 31(1):34-42. PubMed ID: 18157010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavonoid silybin improves the response to radiotherapy in invasive bladder cancer.
    Prack Mc Cormick B; Langle Y; Belgorosky D; Vanzulli S; Balarino N; Sandes E; Eiján AM
    J Cell Biochem; 2018 Jul; 119(7):5402-5412. PubMed ID: 29363820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of target cell infection and natural killer cells in the anti-tumor effects of bacillus Calmette-Guerin in murine bladder cancer.
    Sonoda T; Sugimura K; Ikemoto S; Kawashima H; Nakatani T
    Oncol Rep; 2007 Jun; 17(6):1469-74. PubMed ID: 17487406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting estrogen/estrogen receptor alpha enhances Bacillus Calmette-Guérin efficacy in bladder cancer.
    Shang Z; Li Y; Hsu I; Zhang M; Tian J; Wen S; Han R; Messing EM; Chang C; Niu Y; Yeh S
    Oncotarget; 2016 May; 7(19):27325-35. PubMed ID: 27092883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MB49 murine urothelial carcinoma: molecular and phenotypic comparison to human cell lines as a model of the direct tumor response to bacillus Calmette-Guerin.
    Chen F; Zhang G; Cao Y; Hessner MJ; See WA
    J Urol; 2009 Dec; 182(6):2932-7. PubMed ID: 19853870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacillus Calmette-Guerin induces long-term local formation of nitric oxide in the bladder via the induction of nitric oxide synthase activity in urothelial cells.
    Morcos E; Jansson OT; Adolfsson J; Ehrén I; Wiklund NP
    J Urol; 2001 Feb; 165(2):678-82. PubMed ID: 11176457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guérin induce antitumor immunity in a syngeneic murine bladder cancer model.
    Yoshino T; Miyazaki J; Kojima T; Kandori S; Shiga M; Kawahara T; Kimura T; Naka T; Kiyohara H; Watanabe M; Yamasaki S; Akaza H; Yano I; Nishiyama H
    PLoS One; 2019; 14(1):e0209196. PubMed ID: 30608942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary stimulation from Bacillus Calmette-Guérin induced macrophages induce nitric oxide independent cell-death in bladder cancer cells.
    Thiel T; Ryk C; Chatzakos V; Hallén Grufman K; Bavand-Chobot N; Flygare J; Wiklund NP; de Verdier PJ
    Cancer Lett; 2014 Jun; 348(1-2):119-25. PubMed ID: 24657658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. γ Irradiated Mycobacteria Enhance Survival in Bladder Tumor Bearing Mice Although Less Efficaciously than Live Mycobacteria.
    Noguera-Ortega E; Rabanal RM; Secanella-Fandos S; Torrents E; Luquin M; Julián E
    J Urol; 2016 Jan; 195(1):198-205. PubMed ID: 26165584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of intravesical Bacillus Calmette-Guerin instillations on the expression of inducible nitric oxide synthase in humans.
    Mitropoulos D; Petsis D; Kyroudi-Voulgari A; Kouloukoussa M; Zervas A; Dimopoulos C
    Nitric Oxide; 2005 Aug; 13(1):36-41. PubMed ID: 15964223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGB1 release by urothelial carcinoma cells is required for the in vivo antitumor response to Bacillus Calmette-Guérin.
    Zhang G; Chen F; Cao Y; Johnson B; See WA
    J Urol; 2013 Apr; 189(4):1541-6. PubMed ID: 23041342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.
    Lerner SP; Tangen CM; Sucharew H; Wood D; Crawford ED
    J Urol; 2007 May; 177(5):1727-31. PubMed ID: 17437798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacillus Calmette-Guérin strain differences have an impact on clinical outcome in bladder cancer immunotherapy.
    Rentsch CA; Birkhäuser FD; Biot C; Gsponer JR; Bisiaux A; Wetterauer C; Lagranderie M; Marchal G; Orgeur M; Bouchier C; Bachmann A; Ingersoll MA; Brosch R; Albert ML; Thalmann GN
    Eur Urol; 2014 Oct; 66(4):677-88. PubMed ID: 24674149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoprotection against murine bladder carcinoma by octaarginine-modified liposomes incorporating cell wall of Mycobacterium bovis bacillus Calmette-Guérin.
    Joraku A; Homhuan A; Kawai K; Yamamoto T; Miyazaki J; Kogure K; Yano I; Harashima H; Akaza H
    BJU Int; 2009 Mar; 103(5):686-93. PubMed ID: 19040525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGFBP1 as a potential biomarker predicting bacillus Calmette-Guérin response in bladder cancer.
    Li F; Zhang H; Wang Y; Yao Z; Xie K; Mo Q; Fan Q; Hou L; Deng F; Tan W
    Front Immunol; 2022; 13():954836. PubMed ID: 36119059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGB1 release by urothelial carcinoma cells in response to Bacillus Calmette-Guérin functions as a paracrine factor to potentiate the direct cellular effects of Bacillus Calmette-Guérin.
    Zhang G; Chen F; Cao Y; Amos JV; Shah G; See WA
    J Urol; 2013 Sep; 190(3):1076-82. PubMed ID: 23353043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.